Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Thumbnail

Machine learning helps predict complications, rehospitalizations after PCI

A JACC: Cardiovascular Interventions study published this month suggests machine learning models are more predictive and discriminative than standard methods for identifying patients at the greatest risk of CV mortality and rehospitalization after PCI.

Thumbnail

SCAD: Not Your Typical Heart Attack: New Findings & Increased Visibility Are Changing How Spontaneous Coronary Artery Dissection Is Diagnosed & Treated

Spontaneous coronary artery dissection is emerging from the shadows as an important cause of myocardial infarction in younger women. That visibility is leading to fundamental changes in how the condition is diagnosed and treated.

Tiny sensor tracks blood flow during major heart surgeries

A miniscule fiber-optic sensor could outperform more traditional methods for monitoring blood flow during prolonged and intensive surgical CV procedures, even in the smallest and youngest heart patients, researchers at Flinders University in Australia report.

Thumbnail

Outsourcing Is In: Developing & Integrating Cath Lab Best Practices & Standardization

Sponsored by Terumo

Sometimes a move in the right direction starts with a good hard look in the rearview mirror, then breaking it off to start anew with greater wisdom.

Thumbnail

CV stents market expected to exceed $13B by 2025

The cardiovascular stents market is expected to reach $13.1 billion by 2025, up from $7.8 billion in 2017, according to projections from Fortune Business Insights.

Thumbnail

TCT, VEITHsymposium partner to strengthen conference material

The Cardiovascular Research Foundation is partnering with VEITHsymposium, one of the largest annual meetings in vascular medicine, to enhance conference material at both VEITHsymposium and the CRF’s yearly Transcatheter Cardiovascular Therapeutics conference, the groups announced June 20.

Thumbnail

UNC Children’s suspends complex heart surgeries amid investigation

North Carolina Children’s Hospital will be suspending heart surgeries for its most complex cases for the time being—a direct response to a New York Times investigation that called into question the safety of practices in the center’s pediatric heart surgery unit—the Times reported June 17.

TECAB reduces risk, expedites recovery for bypass patients

Mount Sinai Heart announced June 10 that a pair of its top cardiothoracic surgeons succeeded in performing two totally endoscopic coronary arterial bypass surgeries (TECABs) at the end of May, making the hospital the only center in New York State qualified to offer the procedure.